Global Budesonide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report ID: GIR2112230135 | Category: Pharma & Healthcare | Pages: 105 | Format: PDF | Published Date: October 17,2022

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

The Budesonide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Budesonide market size is estimated to be worth US$ 8440.5 million in 2021 and is forecast to a readjusted size of USD 10420 million by 2028 with a CAGR of 3.1% during review period. Respiratory Disease Treatment accounting for % of the Budesonide global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Injectable Suspension segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Budesonide include AstraZeneca, Teva, Mylan, Sandoz, and Cosmo Pharmaceuticals, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Budesonide market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Injectable Suspension
    Aerosols
    Inhalation Powder
    Tablet and Capsule
Market segment by Application can be divided into
    Respiratory Disease Treatment
    Nose Disease Treatment
    Inflammatory Bowel Disease Treatment
    Others
The key market players for global Budesonide market are listed below:
    AstraZeneca
    Teva
    Mylan
    Sandoz
    Cosmo Pharmaceuticals
    Salix
    Chiesi Farmaceutici
    Orion Corporation
    Cipla
    Synmosa Biopharma
    Lunan Better Pharma
    Shanghai Sine Promod
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Budesonide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Budesonide, with price, sales, revenue and global market share of Budesonide from 2019 to 2022.
Chapter 3, the Budesonide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Budesonide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Budesonide market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Budesonide.
Chapter 13, 14, and 15, to describe Budesonide sales channel, distributors, customers, research findings and conclusion, appendix and data source.

1 Market Overview
    1.1 Budesonide Introduction
    1.2 Market Analysis by Type
        1.2.1 Overview: Global Budesonide Revenue by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Injectable Suspension
        1.2.3 Aerosols
        1.2.4 Inhalation Powder
        1.2.5 Tablet and Capsule
    1.3 Market Analysis by Application
        1.3.1 Overview: Global Budesonide Revenue by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Respiratory Disease Treatment
        1.3.3 Nose Disease Treatment
        1.3.4 Inflammatory Bowel Disease Treatment
        1.3.5 Others
    1.4 Global Budesonide Market Size & Forecast
        1.4.1 Global Budesonide Sales in Value (2017 & 2021 & 2028)
        1.4.2 Global Budesonide Sales in Volume (2017-2028)
        1.4.3 Global Budesonide Price (2017-2028) 
    1.5 Global Budesonide Production Capacity Analysis
        1.5.1 Global Budesonide Total Production Capacity (2017-2028)
        1.5.2 Global Budesonide Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Budesonide Market Drivers
        1.6.2 Budesonide Market Restraints
        1.6.3 Budesonide Trends Analysis
2 Manufacturers Profiles
    2.1 AstraZeneca
        2.1.1 AstraZeneca Details
        2.1.2 AstraZeneca Major Business
        2.1.3 AstraZeneca Budesonide Product and Services
        2.1.4 AstraZeneca Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.2 Teva
        2.2.1 Teva Details
        2.2.2 Teva Major Business
        2.2.3 Teva Budesonide Product and Services
        2.2.4 Teva Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.3 Mylan
        2.3.1 Mylan Details
        2.3.2 Mylan Major Business
        2.3.3 Mylan Budesonide Product and Services
        2.3.4 Mylan Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.4 Sandoz
        2.4.1 Sandoz Details
        2.4.2 Sandoz Major Business
        2.4.3 Sandoz Budesonide Product and Services
        2.4.4 Sandoz Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.5 Cosmo Pharmaceuticals
        2.5.1 Cosmo Pharmaceuticals Details
        2.5.2 Cosmo Pharmaceuticals Major Business
        2.5.3 Cosmo Pharmaceuticals Budesonide Product and Services
        2.5.4 Cosmo Pharmaceuticals Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.6 Salix
        2.6.1 Salix Details
        2.6.2 Salix Major Business
        2.6.3 Salix Budesonide Product and Services
        2.6.4 Salix Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.7 Chiesi Farmaceutici
        2.7.1 Chiesi Farmaceutici Details
        2.7.2 Chiesi Farmaceutici Major Business
        2.7.3 Chiesi Farmaceutici Budesonide Product and Services
        2.7.4 Chiesi Farmaceutici Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.8 Orion Corporation
        2.8.1 Orion Corporation Details
        2.8.2 Orion Corporation Major Business
        2.8.3 Orion Corporation Budesonide Product and Services
        2.8.4 Orion Corporation Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.9 Cipla
        2.9.1 Cipla Details
        2.9.2 Cipla Major Business
        2.9.3 Cipla Budesonide Product and Services
        2.9.4 Cipla Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.10 Synmosa Biopharma
        2.10.1 Synmosa Biopharma Details
        2.10.2 Synmosa Biopharma Major Business
        2.10.3 Synmosa Biopharma Budesonide Product and Services
        2.10.4 Synmosa Biopharma Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.11 Lunan Better Pharma
        2.11.1 Lunan Better Pharma Details
        2.11.2 Lunan Better Pharma Major Business
        2.11.3 Lunan Better Pharma Budesonide Product and Services
        2.11.4 Lunan Better Pharma Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
    2.12 Shanghai Sine Promod
        2.12.1 Shanghai Sine Promod Details
        2.12.2 Shanghai Sine Promod Major Business
        2.12.3 Shanghai Sine Promod Budesonide Product and Services
        2.12.4 Shanghai Sine Promod Budesonide Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Budesonide Breakdown Data by Manufacturer
    3.1 Global Budesonide Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
    3.2 Global Budesonide Revenue by Manufacturer (2019, 2020, 2021, and 2022)
    3.3 Key Manufacturer Market Position in Budesonide
    3.4 Market Concentration Rate
        3.4.1 Top 3 Budesonide Manufacturer Market Share in 2021
        3.4.2 Top 6 Budesonide Manufacturer Market Share in 2021
    3.5 Global Budesonide Production Capacity by Company: 2021 VS 2022
    3.6 Manufacturer by Geography: Head Office and Budesonide Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Budesonide Market Size by Region
        4.1.1 Global Budesonide Sales in Volume by Region (2017-2028)
        4.1.2 Global Budesonide Revenue by Region (2017-2028)
    4.2 North America Budesonide Revenue (2017-2028)
    4.3 Europe Budesonide Revenue (2017-2028)
    4.4 Asia-Pacific Budesonide Revenue (2017-2028)
    4.5 South America Budesonide Revenue (2017-2028)
    4.6 Middle East and Africa Budesonide Revenue (2017-2028)
5 Market Segment by Type
    5.1 Global Budesonide Sales in Volume by Type (2017-2028)
    5.2 Global Budesonide Revenue by Type (2017-2028)
    5.3 Global Budesonide Price by Type (2017-2028)
6 Market Segment by Application
    6.1 Global Budesonide Sales in Volume by Application (2017-2028)
    6.2 Global Budesonide Revenue by Application (2017-2028)
    6.3 Global Budesonide Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
    7.1 North America Budesonide Sales by Type (2017-2028)
    7.2 North America Budesonide Sales by Application (2017-2028)
    7.3 North America Budesonide Market Size by Country
        7.3.1 North America Budesonide Sales in Volume by Country (2017-2028)
        7.3.2 North America Budesonide Revenue by Country (2017-2028)
        7.3.3 United States Market Size and Forecast (2017-2028)
        7.3.4 Canada Market Size and Forecast (2017-2028)
        7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
    8.1 Europe Budesonide Sales by Type (2017-2028)
    8.2 Europe Budesonide Sales by Application (2017-2028)
    8.3 Europe Budesonide Market Size by Country
        8.3.1 Europe Budesonide Sales in Volume by Country (2017-2028)
        8.3.2 Europe Budesonide Revenue by Country (2017-2028)
        8.3.3 Germany Market Size and Forecast (2017-2028)
        8.3.4 France Market Size and Forecast (2017-2028)
        8.3.5 United Kingdom Market Size and Forecast (2017-2028)
        8.3.6 Russia Market Size and Forecast (2017-2028)
        8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
    9.1 Asia-Pacific Budesonide Sales by Type (2017-2028)
    9.2 Asia-Pacific Budesonide Sales by Application (2017-2028)
    9.3 Asia-Pacific Budesonide Market Size by Region
        9.3.1 Asia-Pacific Budesonide Sales in Volume by Region (2017-2028)
        9.3.2 Asia-Pacific Budesonide Revenue by Region (2017-2028)
        9.3.3 China Market Size and Forecast (2017-2028)
        9.3.4 Japan Market Size and Forecast (2017-2028)
        9.3.5 Korea Market Size and Forecast (2017-2028)
        9.3.6 India Market Size and Forecast (2017-2028)
        9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
        9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
    10.1 South America Budesonide Sales by Type (2017-2028)
    10.2 South America Budesonide Sales by Application (2017-2028)
    10.3 South America Budesonide Market Size by Country
        10.3.1 South America Budesonide Sales in Volume by Country (2017-2028)
        10.3.2 South America Budesonide Revenue by Country (2017-2028)
        10.3.3 Brazil Market Size and Forecast (2017-2028)
        10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Budesonide Sales by Type (2017-2028)
    11.2 Middle East & Africa Budesonide Sales by Application (2017-2028)
    11.3 Middle East & Africa Budesonide Market Size by Country
        11.3.1 Middle East & Africa Budesonide Sales in Volume by Country (2017-2028)
        11.3.2 Middle East & Africa Budesonide Revenue by Country (2017-2028)
        11.3.3 Turkey Market Size and Forecast (2017-2028)
        11.3.4 Egypt Market Size and Forecast (2017-2028)
        11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
        11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
    12.1 Raw Material of Budesonide and Key Manufacturers
    12.2 Manufacturing Costs Percentage of Budesonide
    12.3 Budesonide Production Process
    12.4 Budesonide Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
    13.2 Budesonide Typical Distributors
    13.3 Budesonide Typical Customers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Research Process and Data Source
    15.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Budesonide Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?